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Abstract 18 
In dermatology, ointments are often mixed as part of drug therapy, but mixing 19 
often leads to incompatibility.  Three combinations of tetracycline ointment (TC-o) and 20 
acyclovir cream (ACV-cr) were prepared at a TC-o:ACV-cr ratio of 1:1 using a 21 
brand-name ACV-cr and two generic ACV-cr (samples TC-o+ACV-A, TC-o+ACV-B, 22 
and TC-o+ACV-C).  Microscopic examination revealed separation in TC-o+ACV-C. 23 
Viscosity and elasticity measurement indicated that the storage modulus (G’) and loss 24 
modulus (G”) of each of the TC-o+ACV-cr mixtures behaved similarly to those of an 25 
ACV-cr and the loss tangent (tanδ) behaved similarly to that of a TC ointment.  In 26 
addition, differences in the storage modulus (G’) and loss modulus (G”) of the 27 
TC-o+ACV-cr mixtures were noted.  To assess stability, each TC-o+ACV-cr mixture 28 
was stored away from direct sunlight at 25ºC and an RH of 84% and at 4ºC (in a 29 
refrigerator).  HPLC revealed that the ACV content in each TC-o+ACV-cr mixture 30 
remained at 95–105% for up to 14 days under both sets of storage conditions.  A 31 
decline in TC content in each TC-o+ACV-cr mixture was not noted with storage at 4ºC 32 
but was noted over time with storage at 25ºC and an RH of 84%.  In addition, 33 
significant differences in the percent decline in TC content in each TC-o+ACV-cr 34 
mixture occurred with storage at 25ºC and an RH of 84%.  Thus, differences in 35 
physical properties and stability may occur when combining brand-name and generic 36 
drugs, and temperature and humidity may be the cause of the TC-o’s incompatibility. 37 
 38 
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1. Introduction 41 
In dermatology, ointments are often mixed as part of drug therapy to relieve 42 
symptoms and improve feel and compliance (Kizu et al., 2004).  However, there are no 43 
basic data on the clinical effectiveness of and adverse reactions to such mixtures, and 44 
mixing is sometimes done based on experience rather than on evidence (Gao et al., 45 
1994).  There are reports of physical changes and changes in drug penetration 46 
accompanying a decline in content and changes in the characteristics of bases once 47 
ointments are combined (Fukami et al., 2006; Guin et al., 1993; Wohlrab et al., 1984).  48 
In actual practice, many physicians and pharmacists have found that combining 49 
ointments results in separation or deterioration. 50 
Tetracycline hydrochloride (TC), a tetracycline, blocks the binding of aminoacyl 51 
tRNA to the mRNA-ribosome complex.  This inhibits protein synthesis in bacteria and 52 
is why TC has antibacterial action (Xu et al., 2011).  In addition, TC acts specifically 53 
on 70S bacterial ribosomes without acting on 80S animal ribosomes, which is why it is 54 
reported to have selective toxicity (Weisblum et al., 1968).  TC ointments (TC-o) have 55 
been found to be clinically effective in treating impetigo (Kuniyuki et al., 2005). 56 
Impetigo can be caused by an infection due to scratching of the skin.  Chickenpox is 57 
one such condition that causes scratching, and topical preparations of acyclovir (ACV) 58 
that are used to treat herpes-virus infection are also used to treat chickenpox.  Thus, in 59 
actual practice, topical preparations of ACV are sometimes combined with TC-o. A 60 
decline in content and changes in appearance have been reported when combining TC-o 61 
with other preparations (Loseva et al., 1978; Kawamoto et al., 2008).  However, no 62 
studies have described the physical properties and stability of a combination of TC-o 63 
and a topical preparation of ACV. 64 
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Incompatibility due to mixing is often evident not only in the incompatibility of 65 
principal agents but also in the incompatibility of the principal agent and additives (Gao 66 
et al., 1994; Wohlrab et al., 1984).  Differences in bases are known to cause different 67 
levels of incompatibility and differences in drug penetration when combined.  68 
Combining ointments requires selection of bases with similar characteristics (Fukami et 69 
al., 2006; Guin et al., 1993).  The properties of bases of creams and ointments differ, 70 
and combinations of creams and ointments must be studied. ACV cream (ACV-cr) is an 71 
o/w emulsion, and Vaseline (petroleum jelly) is used as an oleaginous base.  There are 72 
both brand-name and generic ACV-cr.  The current authors have studied the 73 
physicochemical properties of ACV-cr and noted differences in the types of additives 74 
and differences in their water content, viscosity, elasticity, and emulsification (Inoue et 75 
al., 2012).  Viscoelasticity is one reported way to assess the physical properties of a 76 
semisolid substance, and the viscoelasticity of conditioners and ointments has been 77 
assessed (Moji et al., 2002; Hong et al., 2010; Kobayashi et al., 1982).  Viscoelasticity 78 
is expressed by the loss tangent (tanδ), which is associated with tackiness due to 79 
differences in emulsification, water content, viscosity and elasticity, and additives. tanδ 80 
may also affect stability. 81 
Thus, the current study assessed the physical properties and stability when 82 
combining TC-o and ACV-cr.  This study also examined incompatibility due to that 83 
combination in order to provide useful information when combining TC-o and ACV-cr. 84 
85 
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2. Materials and Methods 86 
 87 
2.1. Reagents 88 
TC-o (POLA-Pharma Co., Ltd, Japan) and three different 5% ACVs were used in 89 
the present study: the original product, ACV-A (GlaxoSmith Kline K.K.), and the 90 
following two generic products: ACV-B (Sandoz Co., Ltd, Japan) and ACV-C (Toko 91 
Pharmaceutical Industrial Co., Ltd, Japan).  The three products were randomly named 92 
ACV-A, ACV-B, or ACV-C (Table 1).  All other reagents were of special reagent 93 
grade. 94 
 95 
2.2. Sample preparation  96 
The mixture of TC and ACV-c (weight ratio of 1:1) was prepared in a mixer (Nanko 97 
Neritaro NRB-250: THINKY Co., Ltd, Japan).  Conditions for mixing were a mixing 98 
time of 30 s and 2000 rpm.  Distilled water was added to TC-o at a weight ratio of 5%, 99 
10%, and 15% to serve as a mixture of TC-o and distilled water. 100 
 101 
2.3. Microscopy 102 
Polarization microscopy was performed with an Olympus model BX51 microscope 103 
(Olympus Co., Ltd, Japan).  In addition, a polarizing plate with a wavelength of 488 104 
nm was used. 105 
 106 
2.4. Measurement of viscosity and viscoelasticity 107 
Measurement of viscosity or viscoelasticity was done using a Rheometer (HAAKE 108 
MARS; Thermo Scientific Co.) with a 1°’ × R35 cone rotor at 25ºC and 35ºC.  The 109 
conditions for measurement of viscosity were a sample amount of 0.2 mL and a gap of 110 
0.051 mm.  A flow test was used to determine the relative viscosity of all formulations 111 
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with the following parameters: for the upcurve, a continuous ramp with shear rate as 112 
controlled variable (0–1000 s-1), log mode, and a 1-min ramp duration were used.  The 113 
same procedure was used for the downcurve with reversed shear rate (1000–0 s-1) to 114 
measure thixotropy and yield stress.  The conditions for measurement of 115 
viscoelasticity were a sample amount of 2 mL and a gap of 1 mm.  Stress was 116 
increased gradually from 1 Pa to 10 Pa. 117 
tanδ = G” / G’ 118 
tanδ: loss tangent 119 
G”: loss elastic modulus (Pa) 120 
G’: storage elastic modulus (Pa) 121 
 122 
2.5. Preparation of humidification samples 123 
Each TC-o/ACV-cr mixture and each TC-o and distilled water mixture were stored 124 
in a thermostated bath at 25ºC for 0 days, 3 days, 7 days, and 14 days in a desiccator 125 
(relative humidity, 84%) in the presence of a KCl-saturated aqueous solution. 126 
 127 
2.6. HPLC assay 128 
For the assay, 0.5 g of each TC-o/ACV-cr mixture and 0.25 g of TC-o and each 129 
TC-o and distilled water mixture was weighed accurately and placed in a stoppered 130 
centrifuge tube.  Then 40 mL of distilled water was added and the solution was shaken 131 
and then centrifuged (10,000 rpm for 30 min, at 25ºC).  The portion of the lower layer 132 
was filtered with a 0.45-μm filter, and the filtrate served as the sample solution.  A 133 
calibration curve was prepared using TC and ACV that had separately been dried at 134 
105ºC for 24 h.  TC and ACV were assayed using high-performance liquid 135 
chromatography (HPLC: LC-20ADvp, Shimadzu).  TC and ACV assay conditions 136 
were a column of Inertsil ODS-3 (4.6 mm × 250 mm, φ5 μm), column temperature of 137 
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35ºC, mobile phase of pH3 phosphate buffer/methanol = 95/5, and detection wavelength 138 
of 254 nm; conditions were tailored for TC to produce a peak at 9 min.  Multiple 139 
groups were then analyzed with Tukey’s test using the statistical program R 2.1.1. 140 
 141 
2.7. Measurement of water content 142 
The titrimetric determinations of water were performed at room temperature using a 143 
CA-06 Karl-Fisher moisture content meter (Mitsubishi chemical Co., Ltd, Japan) 144 
equipped with a coulometric titration system (n = 3).  Karl-Fischer reagents 145 
(AQUAMICRON○RAX RS as the catholite and AQUAMICRON○RCNU as the anolyte) 146 
were purchased from Mitsubishi Chemical Co.  For measurement, 5-10 mg of sample 147 
was dissolved in Karl Fisher reagent using a glass rod to yield a paste. 148 
 149 
2.8. Measurement of sample pH 150 
The pH was measured directly in each ACV-cr using a Docu-pH Meter (Sartorius 151 
Co., USA).  152 
153 
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3. Results and Discussion 154 
The compatibility of bases is crucial when combining ointments, and 155 
incompatibility of bases can lead to separation and disruption of emulsification (Ohtani 156 
et al., 1997).  Thus, TC-o+ACV-cr mixtures were observed here using polarization 157 
microscopy to determine the dispersion of the mixtures (Fig. 1).  Results revealed the 158 
precipitation of crystals in each TC-o+ACV-cr mixture.  Separation was noted in 159 
TC-o+ACV-C, so emulsification was not uniform, and there were differences in 160 
dispersibility.  In addition, TC-o and ACV-cr were also observed (Fig. 2). Results 161 
revealed crystals in each preparation.  The crystals observed in TC-o were found to be 162 
larger than the crystals found in ACV-cr. In addition, droplets were noted in ACV-C, and 163 
emulsification was found to be non-uniform.  Additives in the TC-o and ACV-cr are 164 
shown in Table 1.  As indicated, there were differences in additives in the ACV-cr.  165 
Instances of differences in the dispersibility of mixtures have been reported even when 166 
combining preparations with the same ingredients (Ohtani et al., 1997).  Differences in 167 
the properties of bases may have affected differences in emulsification in the current 168 
TC-o/ACV-cr mixtures as well.  Thus, differences in dispersibility may have occurred 169 
due to the properties of bases in each ACV-cr. 170 
To determine differences in viscosity and elasticity of the mixtures, the viscosity 171 
and elasticity of the TC-o, ACV-cr, and TC-o+ACV-cr mixtures were measured.  The 172 
measured flow curve is shown in Fig. 3. TC-o and ACV-A had a hysteresis loop while 173 
ACV-B and ACV-C did not.  Thus, the higher water content in ACV-B and ACV-C 174 
than in ACV-A led to ACV-B and ACV-C having no structural memory, which may be 175 
why ACV-B and ACV-C displayed viscoelastic behavior unlike that of ACV-A. In 176 
addition, little memory remained in the TC-o+ACV-cr mixtures.  This was evident 177 
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because of the differences in water content during mixing and suggested that structural 178 
disruption may have occurred. 179 
The storage modulus G’ (the elastic component) and loss modulus G” (the viscous 180 
component) are shown in Fig. 4.  Results for each of the TC-o+ACV-cr mixtures show 181 
that the storage modulus G’ and loss modulus G” behaved not like the elasticity of TC-o 182 
but like ACV-cr, which is interesting.  In short, this is because the structure of the 183 
ointment could not be maintained due to water in the ACV-cr.  In addition, looking at 184 
the behavior of the storage modulus G’ and loss modulus G” of ACV-cr reveals that 185 
there were few disparities between ACV-B and ACV-C but that there were differences 186 
between TC-o+ACV-B and ACV-C. Comparison of ACV-B and TC-o+ACV-B indicated 187 
that TC-o+ACV-B had a larger storage modulus G’ and loss modulus G”.  Comparison 188 
of ACV-C and TC-o+ACV-C indicated that TC-o+ACV-C had a smaller storage 189 
modulus G’ and loss modulus G”.  This was evident from the separation in 190 
TC-o+ACV-C as revealed by microscopic examination.  The water content in ACV-cr 191 
may have had an effect, decreasing its elasticity and viscosity. 192 
The loss tangent tanδ is shown in Fig. 5.  tanδ is a ratio of the loss modulus G”, 193 
which represents the viscosity component, and the storage modulus G’, which 194 
represents the elasticity component (Adeyeye et al., 2002).  The tanδ of each of the 195 
TC-o+ACV-cr mixtures behaved like that of TC-o.  Differences in preparations noted 196 
with ACV-cr decreased.  Thus, each of the TC-o+ACV-cr mixtures was found to have 197 
roughly the same proportion of viscosity and elasticity. 198 
Measurement of viscosity and elasticity revealed differences in the viscosity and 199 
elasticity of TC-o+ACV-cr mixtures.  These differences were evident because of the 200 
differences in water content in the mixtures after mixing and are presumed to have 201 
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caused structural disruption and thus affect stability.  Thus, each TC-o+ACV-cr 202 
mixture was stored away from direct sunlight at 25ºC and an RH of 84% and at 4ºC (in 203 
a refrigerator) to examine the mixtures’ stability.  TC and ACV content were calculated 204 
using HPLC.  Results of the assays of TC and ACV are shown in Table 2.  The ACV 205 
content of ACV-cr has been found to be 95% or higher (Inoue et al., 2012).  The ACV 206 
content in each TC-o+ACV-cr mixture was found to remain at 95–105% for up to 14 207 
days under both sets of storage conditions.  Additionally, the TC content in TC-o and 208 
each TC-o+ACV-cr mixture was 101.8 ± 1.1%, 95.2 ± 1.9%, 99.0 ± 2.1%, and 97.4 ± 209 
1.6%, so the content was found to be 95% or higher.  A decline in TC content in each 210 
TC-o+ACV-cr mixture was not noted over 14 days of storage at 4ºC.  Nevertheless, a 211 
decline in TC content over time was noted with storage at 25ºC and an RH of 84%.  212 
This is presumably because molecular motion is excited by a high temperature and 213 
humidity, for example, storage at 25ºC and an RH of 84%, in comparison to storage at 214 
4ºC. As a result, the mixture is unstable. 215 
A TC-o is reported to have a decline in TC content and a decline in antibacterial 216 
activity when combined with an ointment containing sodium hydroxide (Kawamoto et 217 
al., 2008).  A closer look at additives contained in the ACV-cr indicates that ACV-A 218 
and ACV-C contain additives with Na salts (Table 1).  Thus, Na salts contained in 219 
additives may have caused the decline in TC content noted in TC-o+ACV-A and 220 
TC-o+ACV-C.  However, ACV-B contained no Na salts, so other factors may have 221 
been at work.  Tetracyclines change color and degrade when combined with alkaline 222 
drugs, so caution is required in their handling (Kawamoto et al., 2008).  ACV-A had a 223 
pH of 7.04 ± 0.05, ACV-B had one of 5.17 ± 0.1, and ACV-C had one of 7.29 ± 0.07, so 224 
none were basic.  In addition, degradation by exposure to light is a possibility.  225 
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However, under the current storage conditions, mixtures were stored away from direct 226 
sunlight, so light was not a factor.  In addition, TC is known to undergo hydrolysis 227 
(Kang et al., 2012).  Thus, attention was focused on the water content in each ACV-cr. 228 
The water content in each TC-o+ACV-cr mixture was measured.  TC-o+ACV-A 229 
had a water content of 6.0 ± 1.4, TC-o+ACV-B had one of 14.3 ± 0.8, and 230 
TC-o+ACV-C had one of 12.1 ± 0.6% before storage.  Given the fact that water 231 
content can affect stability, distilled water was mixed with TC-o to a weight ratio of 5%, 232 
10%, and 15% and the TC content in each mixture was examined.  Results revealed no 233 
changes in content with storage at 4ºC.  In contrast, a decline in TC content was noted 234 
with storage at 25ºC and an RH of 84% (Table 3).  Significant differences in the 235 
decline in TC content were not noted in any of the mixtures stored at 25ºC and an RH of 236 
84%.  Thus, water presumably caused a decline in TC content, as did differences in the 237 
storage temperature and additives. 238 
In addition, significant differences in the decline in TC content over time were noted 239 
in each TC-o+ACV-cr mixture stored at 25ºC and an RH of 84%.  TC-o+ACV-A and 240 
TC-o+ACV-B had a greater percent decline in TC content than TC-o+ACV-C (Table 2).  241 
One cause of this may have been differences in separation as revealed by microscopic 242 
examination.  Separation was noted in TC-o+ACV-C though not in TC-o+ACV-A and 243 
TC-o+ACV-B.  Thus, the TC-o in TC-o+ACV-A and TC-o+ACV-B was dispersed in 244 
ACV-cr in an o/w manner.  The TC-o in TC-o+ACV-A and TC-o+ACV-B was in 245 
contact with the additives and water in the ACV-cr.  Thus, TC-o+ACV-A and 246 
TC-o+ACV-B had greater incompatibility of TC-o and ACV-cr than did TC-o+ACV-C, 247 
facilitating a decline in TC content. 248 
The current study noted differences in separation, viscosity, and elasticity as a result 249 
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of combining TC-o and ACV-cr.  Differences in physical properties may lead to 250 
differences in feel and can affect patient compliance and adherence as well.  With 251 
regard to the stability of each TC-o+ACV-cr mixture, a decline in TC content over time 252 
was noted due to differences in storage conditions.  The decline in TC content in the 253 
TC-o+ACV-cr mixtures is attributed to storage conditions, suggesting the importance of 254 
how such mixtures are stored. 255 
Differences in the physical properties of and storage conditions for preparations may 256 
lead to differences in clinical effectiveness.  In addition, differences in the types and 257 
ratios of additives are reported to affect skin penetration (Trottet et al., 2005).  258 
Differences in the types and ratios of additives may also lead to differences in clinical 259 
effectiveness.  Detailed information on the physical properties and content of 260 
brand-name and generic drugs can be a useful piece of information when determining 261 
what drugs are safe and efficacious to combine. 262 
 263 
Conclusion 264 
The current study found differences in separation, viscosity, and elasticity in 265 
combinations of a TC-o and ACV-cr.  With regard to the stability of the TC-o+ACV-cr 266 
mixtures, a decline in TC content over time was noted due to differences in storage 267 
conditions.  In addition, the decline in TC content in TC-o+ACV-cr mixtures is 268 
attributed to storage conditions.  Thus, differences in physical properties may occur 269 
when combining brand-name and generic drugs, and water content and humidity may be 270 
the cause of the TC-o’s incompatibility. 271 
 272 
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Figure legends 330 
Table 1. Additives list for TC-o and ACV-cr 331 
 332 
Table 2. The mean ACV and TC content in TC-o+ACV-cr mixtures according to HPLC 333 
(±SD, n = 3) 334 
 335 
Table 3. The mean TC content in TC-o according to HPLC (±SD, n = 3)  336 
 337 
Fig. 1 Light microscopy of TC-o/ACV-cr mixtures. Scale bars indicate 50 μm. 338 
a) TC-o+ACV-A, 0 days after mixing; b) TC-o+ACV-B, 0 days after mixing; c) 339 
TC-o+ACV-C, 0 days after mixing; d) TC-o+ACV-A, 14 days after mixing at 25ºC 340 
RH84%; e) TC-o+ACV-B, 14 days after mixing at 25ºC RH84%; f) TC-o+ACV-C, 14 341 
days after mixing at 25ºC RH84%; g) TC-o+ACV-A, 14 days after mixing at 4ºC; h) 342 
TC-o+ACV-B, 14 days after mixing at 4ºC; i) TC-o+ACV-C, 14 days after mixing at 343 
4ºC  344 
 345 
Fig. 2 Light microscopy of TC ointment and ACV creams respectively. Scale bars 346 
indicate 50 μm. 347 
a) TC-o, b) ACV-A, c) ACV-B, d) ACV-C 348 
 349 
Fig. 3 Shear stress versus shear speed curves for TC-o, ACV-cr, and TC-o+ACV-cr 350 
mixtures at 25ºC 351 
a) Shear stress versus shear speed curves for TC-o and ACV-cr 352 
○: TC-o, ◆: ACV-A, □: ACV-B, △: ACV-C 353 
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b） Shear stress versus shear speed curves for TC-o+ACV-cr mixtures 354 
◆: TC-o+ACV-A, □: TC-o+ACV-B, △: TC-o+ACV-C 355 
 356 
Fig. 4 G’ and G” versus Tau for TC-o, ACV-cr, and TC-o+ACV-cr mixtures 357 
a) G’ versus Tau for TC-o and ACV-cr, b) G” versus Tau for TC-o and ACV-cr 358 
○: TC-o, ◆: ACV-A, □: ACV-B, △: ACV-C 359 
c) G’ versus Tau for TC-o+ACV-cr mixtures, d) G” versus Tau for TC-o+ACV-cr 360 
mixtures 361 
◆: TC-o+ACV-A, □: TC-o+ACV-B, △: TC-o+ACV-C 362 
 363 
Fig. 5 tanδ versus Tau for TC-o, ACV-cr, and TC-o+ACV-cr mixtures 364 
a) tanδ versus Tau for TC-o and ACV-cr 365 
○: TC-o, ◆: ACV-A, □: ACV-B, △: ACV-C 366 
b) tanδ versus Tau for TC-o+ACV-cr mixtures 367 
◆: TC-o+ACV-A, □: TC-o+ACV-B, △: TC-o+ACV-C 368 
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